Lv1
52 积分 2023-08-09 加入
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models
14天前
已完结
Autosomal Dominant Polycystic Kidney Disease
18天前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
25天前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
25天前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
25天前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
26天前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: a randomized, double-blind, placebo-controlled study
1个月前
已完结
New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024
2个月前
已完结
Nonalcoholic Steatohepatitis
2个月前
已完结
Fibroblast growth factor 21: A “rheostat” for metabolic regulation?
2个月前
已完结
皖公网安备34019202002308
